EPISODE · Dec 12, 2022 · 21 MIN
Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria
from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier · host UCARE, the Global Allergy and Asthma Excellence Network for Urticaria
Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.
NOW PLAYING
Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria
No transcript for this episode yet
Similar Episodes
No similar episodes found.